From shutdown orders to regulatory waivers, trillion-dollar federal aid laws, public health guidelines and reopening orders, the COVID-19 emergency has produced thousands of pages of new regulations. With the healthcare industry at the center of many of these changes, understanding these new regulations has never been more important for physician practices in these turbulent times. Meanwhile, the 2020 election is quickly approaching and this summer will bring CMS’s annual rulemaking cycle back into focus. Wondering how these regulatory changes will impact your practice and what to expect next?
After this webinar, you will be able to:
- Hear about key COVID-19 federal government regulations and laws that will impact physician groups.
- Understand the healthcare policy impacts of the pandemic and what changes might be made permanent after it ends.
About the Speaker:
Chris Emper, JD, MBA, is President of Emper Healthcare Advisors, a health IT industry advisory and consulting services firm in Washington, D.C. that specializes in helping healthcare providers and technology companies successfully navigate and comply with complex regulations and value-based reimbursement models. Prior to forming Emper Healthcare Advisors in 2016, Chris was Vice President of Government Affairs at NextGen Healthcare (NASDAQ: QSII) and Chair of the Electronic Health Record Association (EHRA) Public Policy committee. An expert in The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and The Patient Protection and Affordable Care Act (ACA), Chris is a frequent speaker at industry conferences and has written or appeared in articles in publications such as Politico, Health Data Management, Accountable Care News and Medical Economics. Chris also currently serves as Chair of the HIMSS Government Relations Roundtable, a leading coalition of health IT government affairs professionals. Prior to joining NextGen Healthcare in 2013, Chris served as a Domestic Policy Advisor for former Massachusetts Governor Mitt Romney’s 2012 Presidential Campaign, where he advised on policy issues including healthcare, technology and innovation. He holds a law degree and an MBA from Villanova University and a BA from Boston College.